Changzhen Shang
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Hepatology top 2%
- Surgery
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (18 papers)Liver physiology and pathology (10 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- Journal of Biological ChemistryJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Changzhen Shang
59 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Molecular Biology 920
- Cancer Research 581
- Oncology 436
- Hepatology 429
- Surgery 255
Countries citing papers authored by Changzhen Shang
This map shows the geographic impact of Changzhen Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changzhen Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changzhen Shang more than expected).
Fields of papers citing papers by Changzhen Shang
This network shows the impact of papers produced by Changzhen Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changzhen Shang. The network helps show where Changzhen Shang may publish in the future.
Co-authorship network of co-authors of Changzhen Shang
This figure shows the co-authorship network connecting the top 25 collaborators of Changzhen Shang. A scholar is included among the top collaborators of Changzhen Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changzhen Shang. Changzhen Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 4 | |
| 7 | 11 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression | 9 |
| 11 | 28 | |
| 12 | 16 | |
| 13 | 39 | |
| 14 | 4 | |
| 15 | 66 | |
| 16 | 21 | |
| 17 | 186 | |
| 18 | 38 | |
| 19 | 4 | |
| 20 | 381 |
About Changzhen Shang
Changzhen Shang is a scholar working on Hepatology, Cancer Research and Oncology, having authored 65 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Liver physiology and pathology (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). The work is most often cited by research in Hepatology (429 citations), Cancer Research (581 citations) and Oncology (436 citations). Changzhen Shang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Yajin Chen, Min Jun, Haoming Lin, Lihong Lv, Yun-Le Wan, Wenliang Tan, Guolin Li, Yan Lin, Mei Yang and Wei Zhang. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.